NO971110L - Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin - Google Patents
Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipinInfo
- Publication number
- NO971110L NO971110L NO971110A NO971110A NO971110L NO 971110 L NO971110 L NO 971110L NO 971110 A NO971110 A NO 971110A NO 971110 A NO971110 A NO 971110A NO 971110 L NO971110 L NO 971110L
- Authority
- NO
- Norway
- Prior art keywords
- pallidipine
- asp
- platelet aggregation
- amino acid
- aspartic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
En fremgangsmåte for fremstil- ling av et rekombinant protein betegnet Asp-pallidipin. Asp-pallidipin inhiberer den kollageninduserte blod- plateaggregering av pattedyrblodplater. Asp-pallidipin omfatter (i) et protein (pallidipin) utvalgt fra gruppen av pallidipin- proteiner, og (ii) aminosyren asparaginsyre, hvori asparaginsyren er forbundet ved hjelp av en peptidbinding med den N- terminale ende av pallidipinet. Frem- gangsmåten omfatter trinnene aa) transfeksjon av minst én bakterie med en egnet vektor, hvori vektoren omfatter: (i) et DNA eller cDNA som koder for rekombinant Asp-pallidipin, (ii) en egnet signalpeptidsekvens som spaltes slik at aminosyren asparaginsyre befinner seg i posisjon +1 i aminosyresekvensen sett fra posisjonen av pallidipinet, og (iii) en egnet promoter; bb) ekspresjon av preproteinet om- fattende Asp-pallidipin og signal- sekvensen; cc) transport av Asp-pallidipin fra bakteriens cytoplasma til periplasma, spalting av preproteinet ved hjelp av minst én protease under transporten, for produksjon av Asp-pallidipin, dd) isolering av Asp-pallidipin ved ekstraksjon av periplasmaet, og ee) rensing av Asp-pallidipin. Proteinet anvendes som et medikament for inhibering av kollagenindusert human blodplateaggregering eller av cancer med metastatiske tumorceller.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94250224 | 1994-09-12 | ||
| PCT/EP1995/003573 WO1996008563A1 (en) | 1994-09-12 | 1995-09-11 | Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971110D0 NO971110D0 (no) | 1997-03-11 |
| NO971110L true NO971110L (no) | 1997-05-07 |
Family
ID=8217517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971110A NO971110L (no) | 1994-09-12 | 1997-03-11 | Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5882887A (no) |
| EP (1) | EP0781334A1 (no) |
| JP (1) | JPH10505502A (no) |
| CN (1) | CN1075836C (no) |
| AU (1) | AU701643B2 (no) |
| BG (1) | BG63276B1 (no) |
| BR (1) | BR9508910A (no) |
| CA (1) | CA2199719A1 (no) |
| CZ (1) | CZ76297A3 (no) |
| FI (1) | FI971013A0 (no) |
| HU (1) | HU222398B1 (no) |
| IL (1) | IL115272A0 (no) |
| MX (1) | MX9701720A (no) |
| NO (1) | NO971110L (no) |
| NZ (1) | NZ293261A (no) |
| PL (1) | PL184617B1 (no) |
| RO (1) | RO117971B1 (no) |
| RU (1) | RU2186110C2 (no) |
| SI (1) | SI9520093A (no) |
| SK (1) | SK29297A3 (no) |
| WO (1) | WO1996008563A1 (no) |
| ZA (1) | ZA957649B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU228068B1 (en) * | 1999-03-18 | 2012-09-28 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
| CA2578072A1 (en) * | 2004-12-28 | 2006-07-06 | Ares Trading S.A. | Compositions and methods for treating schizophrenia and related disorders |
| US7691839B2 (en) | 2005-09-28 | 2010-04-06 | Biovascular, Inc. | Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
| US20110034396A1 (en) * | 2005-09-28 | 2011-02-10 | Biovascular, Inc. | Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions |
| TWI391143B (zh) * | 2005-11-04 | 2013-04-01 | Otsuka Pharma Co Ltd | 血小板凝集抑制劑組成物 |
| WO2012172427A2 (en) * | 2011-06-14 | 2012-12-20 | National Taiwan University | Peptide compounds for inhibition of platelet aggregation |
| FR2979346B1 (fr) | 2011-08-23 | 2013-09-27 | Univ Joseph Fourier | Nanocorps anti-vcam-1 |
| SG10201604810UA (en) | 2012-02-07 | 2016-08-30 | Global Bio Therapeutics Inc | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| CN104837865B (zh) | 2012-09-07 | 2019-09-24 | 国立健康与医学研究所 | 衍生自髓样细胞触发受体-1(trem-1)trem-样转录物1(tlt-1)的抑制肽及其用途 |
| MX2016001667A (es) | 2013-08-08 | 2016-11-07 | Global Bio Therapeutics Inc | Dispositivo de sujecion para procedimientos minimamente invasivos y usos del mismo. |
| FR3058143B1 (fr) | 2016-10-27 | 2021-03-12 | Univ Grenoble Alpes | Nanocorps anti-tau |
| EP4340855A1 (en) | 2021-08-13 | 2024-03-27 | Triovance Holding LLC | A skin substitute composition and methods of producing and using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988010299A1 (en) * | 1987-06-24 | 1988-12-29 | Novo-Nordisk A/S | A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation |
| HU218830B (hu) * | 1991-09-05 | 2000-12-28 | Schering Ag. | Eljárás kollagénindukált vérlemezke-koaguláció inhibitor előállítására |
| US5756454A (en) * | 1991-09-05 | 1998-05-26 | Schering Aktiengesellschaft | Collagen-induced platelet aggregation inhibitor |
| US5705362A (en) * | 1992-05-25 | 1998-01-06 | Gist-Brocades, N.V. | Modified signal sequences |
-
1995
- 1995-09-11 NZ NZ293261A patent/NZ293261A/en unknown
- 1995-09-11 AU AU35657/95A patent/AU701643B2/en not_active Ceased
- 1995-09-11 CA CA002199719A patent/CA2199719A1/en not_active Abandoned
- 1995-09-11 SK SK292-97A patent/SK29297A3/sk unknown
- 1995-09-11 EP EP95932714A patent/EP0781334A1/en not_active Withdrawn
- 1995-09-11 JP JP8509898A patent/JPH10505502A/ja not_active Ceased
- 1995-09-11 CN CN95195002A patent/CN1075836C/zh not_active Expired - Fee Related
- 1995-09-11 US US08/793,294 patent/US5882887A/en not_active Expired - Fee Related
- 1995-09-11 CZ CZ97762A patent/CZ76297A3/cs unknown
- 1995-09-11 RO RO97-00444A patent/RO117971B1/ro unknown
- 1995-09-11 BR BR9508910A patent/BR9508910A/pt not_active Application Discontinuation
- 1995-09-11 HU HU9701823A patent/HU222398B1/hu not_active IP Right Cessation
- 1995-09-11 MX MX9701720A patent/MX9701720A/es unknown
- 1995-09-11 PL PL95319078A patent/PL184617B1/pl unknown
- 1995-09-11 SI SI9520093A patent/SI9520093A/sl unknown
- 1995-09-11 WO PCT/EP1995/003573 patent/WO1996008563A1/en not_active Application Discontinuation
- 1995-09-11 RU RU97105821/13A patent/RU2186110C2/ru not_active IP Right Cessation
- 1995-09-12 ZA ZA957649A patent/ZA957649B/xx unknown
- 1995-09-12 IL IL11527295A patent/IL115272A0/xx unknown
-
1997
- 1997-02-12 BG BG101226A patent/BG63276B1/bg unknown
- 1997-03-11 FI FI971013A patent/FI971013A0/fi unknown
- 1997-03-11 NO NO971110A patent/NO971110L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI9520093A (en) | 1997-08-31 |
| RO117971B1 (ro) | 2002-11-29 |
| RU2186110C2 (ru) | 2002-07-27 |
| NZ293261A (en) | 1998-11-25 |
| AU701643B2 (en) | 1999-02-04 |
| CN1075836C (zh) | 2001-12-05 |
| FI971013A (fi) | 1997-03-11 |
| HU222398B1 (hu) | 2003-06-28 |
| MX9701720A (es) | 1997-06-28 |
| HUT76972A (hu) | 1998-01-28 |
| PL319078A1 (en) | 1997-07-21 |
| ZA957649B (en) | 1996-04-15 |
| BG101226A (en) | 1998-10-30 |
| PL184617B1 (pl) | 2002-11-29 |
| FI971013A0 (fi) | 1997-03-11 |
| NO971110D0 (no) | 1997-03-11 |
| CZ76297A3 (cs) | 1998-01-14 |
| BR9508910A (pt) | 1997-10-28 |
| JPH10505502A (ja) | 1998-06-02 |
| CA2199719A1 (en) | 1996-03-21 |
| AU3565795A (en) | 1996-03-29 |
| BG63276B1 (bg) | 2001-08-31 |
| WO1996008563A1 (en) | 1996-03-21 |
| EP0781334A1 (en) | 1997-07-02 |
| SK29297A3 (en) | 1997-10-08 |
| US5882887A (en) | 1999-03-16 |
| IL115272A0 (en) | 1995-12-31 |
| CN1159828A (zh) | 1997-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| George-Nascimento et al. | Characterization of recombinant human epidermal growth factor produced in yeast | |
| CN100500853C (zh) | 用于向细菌培养物上清液中分泌目的蛋白质的融合蛋白质 | |
| Steiner et al. | Golgi/granule processing of peptide hormone and neuropeptide precursors: a minireview | |
| NO971110L (no) | Fremgangsmåte for fremstilling av en modifisert, kollagenindusert blodplateaggregeringsinhibitor, pallidipin | |
| KR880014110A (ko) | 인체 프로아포지방단백질 a-i의 발현 | |
| NZ510385A (en) | E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of the MST peptide and a heterologous protein, such as human growth hormone | |
| CA2032153A1 (fr) | Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant | |
| DK1356073T3 (da) | Fermenteringsfremgangsmåde til fremstilling af heterologe genprodukter i mælkesyrebakterier | |
| CZ636081A3 (en) | Process for preparing a vector for dna transfer | |
| Claeys et al. | Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin | |
| Rabbani et al. | Recombinant human parathyroid hormone synthesized in Escherichia coli. Purification and characterization. | |
| EP0871474A1 (en) | Generation of human insulin | |
| RU2010127232A (ru) | Рекомбинантные белки эластазы и способы их получения и применения | |
| DE69906509D1 (de) | Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen | |
| WO2022227707A1 (zh) | 一种双靶点融合蛋白的制备方法和应用 | |
| Cristina Leite Mulder et al. | Critical aspects to be considered prior to large-scale production of peptides | |
| JPH10511845A (ja) | 細菌において細胞外タンパク質を製造するための方法 | |
| IL99079A0 (en) | Protein structure of the plant toxin gelonin | |
| Allen et al. | Production of epidermal growth factor in Escherichia coli from a synthetic gene | |
| RU97105821A (ru) | Способ производства модифицированного ингибитора индуцированной коллагеном агрегации тромбоцитов паллидипина | |
| Mikhailova et al. | Autolysis of bovine enteropeptidase heavy chain: evidence of fragment 118–465 involvement in trypsinogen activation | |
| CA2198966A1 (en) | Method for cleaving chimeric protein using processing enzyme | |
| GR3023348T3 (en) | Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria. | |
| CN111087475B (zh) | Fgf21融合蛋白及抑制其降解的方法 | |
| Takahashi et al. | The amino acid sequence of ribonuclease U1, a guanine-specific ribonuclease from the fungus Ustilago sphaerogena |